Phase 1 Study of BXCL701, a Dipeptidyl Peptidase Inhibitor, in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome-MedSci.cn

Phase 1 Study of BXCL701, a Dipeptidyl Peptidase Inhibitor, in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Winer, ES; Garcia, JS; Stone, RM; Wadleigh, M; Luskin, MR; Stahl, M; Chen, EC; Leonard, R; Noyes, A; Galinsky, I; Deshpande, R; Borderies, P; O'Neill, V; DeAngelo, DJ

BLOOD, 2023; 142 ():

科室
- - 订阅+
  - 更多科室
工具
服务